Gelonghui May 10 丨 Yiqiao Shenzhou (301047.SZ) held a performance briefing on May 9, 2024 to discuss “What is the company's business share in scientific research institutions and pharmaceutical companies?” The company replied that the company's product line covers a wide range of products and can be used to support basic life science research by scientific research institutions and innovative research and development by pharmaceutical companies, and that there are different domestic and international competition situations in different fields of reagents and services. Currently, pharmaceutical companies account for a relatively large share of direct sales revenue.
义翘神州(301047.SZ)：目前在直销收入中，医药企业占比相对较大
Yiqiao Shenzhou (301047.SZ): Currently, pharmaceutical companies account for a relatively large share of direct sales revenue
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.